# Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)

> **NCT03156582** · — · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 562 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** Data collecting

## Key facts

- **NCT ID:** NCT03156582
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-04-01
- **Target enrollment:** 562 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03156582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03156582, "Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03156582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*